Harmony Biosciences Holdings (HRMY)
NASDAQ:HRMY
US Market
Holding HRMY?
Track your performance easily

Harmony Biosciences Holdings (HRMY) Financial Statements

195 Followers

Harmony Biosciences Holdings Financial Overview

Harmony Biosciences Holdings's market cap is currently ―. The company's EPS TTM is $1.952; its P/E ratio is 17.82; Harmony Biosciences Holdings is scheduled to report earnings on October 29, 2024, and the estimated EPS forecast is $0.69. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 172.81M$ 154.62M$ 168.41M$ 160.27M$ 134.22M
Gross Profit$ 140.67M$ 127.13M$ 125.26M$ 127.97M$ 109.21M
EBIT$ 26.10M$ 56.32M-$ 63.63M$ 56.11M
EBITDA$ 32.92M$ 62.03M-$ 70.27M$ 61.92M
Net Income Common Stockholders$ 11.59M$ 38.33M$ 26.61M$ 38.46M$ 34.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 346.91M$ 372.35M$ 353.46M$ 370.67M$ 370.98M
Total Assets$ 858.38M$ 846.99M$ 811.45M$ 777.77M$ 760.18M
Total Debt$ 186.42M$ 190.00M$ 193.57M$ 197.13M$ 191.49M
Net Debt$ -160.49M$ -182.35M$ -159.89M$ -173.54M$ -179.50M
Total Liabilities$ 319.80M$ 331.59M$ 344.46M$ 296.43M$ 275.01M
Stockholders Equity$ 538.58M$ 515.39M$ 466.99M$ 481.33M$ 485.17M
Cash Flow-
Free Cash Flow$ 41.98M$ 31.14M-$ 63.10M$ 36.86M
Operating Cash Flow$ 42.62M$ 31.14M$ 76.67M$ 63.10M$ 37.06M
Investing Cash Flow$ -54.86M$ -6.19M$ -36.06M$ -813.00K$ -7.77M
Financing Cash Flow$ -3.45M$ -3.63M$ -53.52M$ -55.10M$ -339.00K
Currency in USD

Harmony Biosciences Holdings Earnings and Revenue History

Harmony Biosciences Holdings Debt to Assets

Harmony Biosciences Holdings Cash Flow

Harmony Biosciences Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis